Back to today’s briefing

Story perspectives

Study Reveals TP53 Mutation Status Trumps p53 Expression in Cancer

2/1/2025

50 9

Summary

Story summary

A groundbreaking study at the 2025 SGO Winter Meeting reveals that p53 protein expression fails to reliably indicate TP53 mutation status in high-risk endometrial cancer patients. Out of 382 participants, 66% exhibited abnormal p53 expression, yet 73% had TP53 mutations, highlighting the potential of TP53 mutation status as a more accurate prognostic marker.

1 of 1

Story summary

A groundbreaking study at the 2025 SGO Winter Meeting reveals that p53 protein expression fails to reliably indicate TP53 mutation status in high-risk endometrial cancer patients. Out of 382 participants, 66% exhibited abnormal p53 expression, yet 73% had TP53 mutations, highlighting the potential of TP53 mutation status as a more accurate prognostic marker.